Viewing Study NCT04616105


Ignite Creation Date: 2025-12-25 @ 3:10 AM
Ignite Modification Date: 2025-12-26 @ 1:49 AM
Study NCT ID: NCT04616105
Status: TERMINATED
Last Update Posted: 2021-11-11
First Post: 2020-10-29
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of the Safety, Tolerability, and Pharmacokinetics of REGN6490 in Healthy Japanese Adult Volunteers
Sponsor: Regeneron Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module